7-30616026-C-G
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_002047.4(GARS1):c.1162C>G(p.Arg388Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000062 in 1,614,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R388W) has been classified as Uncertain significance.
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease type 2DInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- neuronopathy, distal hereditary motor, type 5AInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
- spinal muscular atrophy, infantile, James typeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GARS1 | ENST00000389266.8 | c.1162C>G | p.Arg388Gly | missense_variant | Exon 9 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
| GARS1 | ENST00000675651.1 | c.1162C>G | p.Arg388Gly | missense_variant | Exon 9 of 17 | ENSP00000502513.1 | ||||
| GARS1 | ENST00000675810.1 | c.1060C>G | p.Arg354Gly | missense_variant | Exon 8 of 16 | ENSP00000502743.1 | ||||
| GARS1 | ENST00000675693.1 | c.994C>G | p.Arg332Gly | missense_variant | Exon 10 of 18 | ENSP00000502174.1 | ||||
| GARS1 | ENST00000675051.1 | c.961C>G | p.Arg321Gly | missense_variant | Exon 9 of 17 | ENSP00000502296.1 | ||||
| GARS1 | ENST00000674815.1 | c.793C>G | p.Arg265Gly | missense_variant | Exon 9 of 17 | ENSP00000502799.1 | ||||
| GARS1 | ENST00000674851.1 | c.793C>G | p.Arg265Gly | missense_variant | Exon 10 of 18 | ENSP00000502451.1 | ||||
| GARS1 | ENST00000444666.6 | n.1162C>G | non_coding_transcript_exon_variant | Exon 9 of 18 | 3 | ENSP00000415447.2 | ||||
| GARS1 | ENST00000674616.1 | n.*876C>G | non_coding_transcript_exon_variant | Exon 10 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674643.1 | n.*262C>G | non_coding_transcript_exon_variant | Exon 10 of 17 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000674737.1 | n.*500C>G | non_coding_transcript_exon_variant | Exon 10 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000674807.1 | n.1162C>G | non_coding_transcript_exon_variant | Exon 9 of 16 | ENSP00000502814.1 | |||||
| GARS1 | ENST00000675529.1 | n.*1032C>G | non_coding_transcript_exon_variant | Exon 10 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000675859.1 | n.1162C>G | non_coding_transcript_exon_variant | Exon 9 of 15 | ENSP00000502033.1 | |||||
| GARS1 | ENST00000676088.1 | n.*1104C>G | non_coding_transcript_exon_variant | Exon 11 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676140.1 | n.*107C>G | non_coding_transcript_exon_variant | Exon 9 of 17 | ENSP00000502571.1 | |||||
| GARS1 | ENST00000676164.1 | n.*613C>G | non_coding_transcript_exon_variant | Exon 9 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*451C>G | non_coding_transcript_exon_variant | Exon 10 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*594C>G | non_coding_transcript_exon_variant | Exon 9 of 17 | ENSP00000501980.1 | |||||
| GARS1 | ENST00000676403.1 | n.1162C>G | non_coding_transcript_exon_variant | Exon 9 of 16 | ENSP00000502681.1 | |||||
| GARS1 | ENST00000674616.1 | n.*876C>G | 3_prime_UTR_variant | Exon 10 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674643.1 | n.*262C>G | 3_prime_UTR_variant | Exon 10 of 17 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000674737.1 | n.*500C>G | 3_prime_UTR_variant | Exon 10 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000675529.1 | n.*1032C>G | 3_prime_UTR_variant | Exon 10 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000676088.1 | n.*1104C>G | 3_prime_UTR_variant | Exon 11 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676140.1 | n.*107C>G | 3_prime_UTR_variant | Exon 9 of 17 | ENSP00000502571.1 | |||||
| GARS1 | ENST00000676164.1 | n.*613C>G | 3_prime_UTR_variant | Exon 9 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*451C>G | 3_prime_UTR_variant | Exon 10 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*594C>G | 3_prime_UTR_variant | Exon 9 of 17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000802 AC: 2AN: 249522 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74318 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.R388G variant (also known as c.1162C>G), located in coding exon 9 of the GARS gene, results from a C to G substitution at nucleotide position 1162. The arginine at codon 388 is replaced by glycine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Charcot-Marie-Tooth disease type 2 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 388 of the GARS protein (p.Arg388Gly). This variant is present in population databases (rs759277467, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with GARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 965772). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GARS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at